Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.32 |
| ▸ | FYN | P06241 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | AHR | P35869 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.32 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22652679 | 1.00 | MEN1 (0.36) | MEN1RAB9AKMT2ACYP1A2CYP3A4 | |
| SCHEMBL25006625 | 0.86 | MEN1 (0.36) | MEN1RAB9AKMT2ACYP1A2CYP3A4 | |
| SCHEMBL25005766 | 0.86 | MEN1 (0.36) | MEN1RAB9AKMT2ACYP1A2CYP3A4 | |
| SCHEMBL22652637 | 0.85 | MEN1 (0.39) | MEN1RAB9AKMT2ACYP1A2ESR1 | |
| SCHEMBL22652664 | 0.85 | MEN1 (0.39) | MEN1RAB9AKMT2ACYP1A2ESR1 | |
| SCHEMBL22652706 | 0.85 | KDM4E (0.30) | — | |
| SCHEMBL22652675 | 0.82 | ESR1 (0.36) | MEN1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL22652638 | 0.82 | ESR1 (0.36) | MEN1KMT2ACYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14700527 | 0.82 | DHODH (0.36) | MEN1RAB9AKMT2AAHR | |
| SCHEMBL22916770 | 0.81 | CYP11B1 (0.39) | MEN1KMT2ACYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230047477-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| US-20230042023-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| US-11552252-B1 | — | — | 2023-01-10 | — | — | US | disclosed |
| US-11271164-B2 | Compound, composition, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD (JP) | 2022-03-08 | — | — | US | disclosed |
| US-20200358000-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200358000-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | PAX2, CXXC4, XDH | MEN1 1911/4885RAB9A 2260/4885KMT2A 2191/4885 |
| US-11271164-B2 | Compound, composition, organic electroluminescent element and electronic device | PAX2, CXXC4, XDH | MEN1 1911/4885RAB9A 2260/4885KMT2A 2191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.